| Dr Manuel A Rivero Iturregui, MD | |
|
1760 Calle Loiza, Suite 203, San Juan, PR 00911-1801 | |
| (787) 726-5486 | |
| (787) 728-6031 |
| Full Name | Dr Manuel A Rivero Iturregui |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 35 Years |
| Location | 1760 Calle Loiza, San Juan, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861477580 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 11419 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Puerto Rico Pathology Associates P | 4385655760 | 14 |
News Archive
Hospitals still struggle to prevent avoidable healthcare-associated infections, according to a survey of infection preventionists released today by the Association for Professionals in Infection Control and Epidemiology. Half of those surveyed agree that catheter-related bloodstream infections continue to be a problem in their facilities and cite lack of time, resources, and the commitment of hospital leadership as hindering their ability to combat these infections more aggressively.
Research with a Finnish background facilitates the development of more effective cancer medication. Cancer cells have an exceptional ability to repair damage to their DNA caused during uncontrolled cell division.
An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma - pointing to a potential new target for treatment against the illness.
For a long time it has been known that the protein TOR - Target of Rapamycin - controls cell growth and is involved in the development of diseases such as cancer and diabetes. Researchers at the University of Basel's Biozentrum together with scientists from ETH Zurich have now examined the structure of mammalian TOR complex 1 (mTORC1) in more detail.
Nature can reset the clock in certain types of cancer and reverse many of the elements responsible for causing malignancy, reports a research team led by Whitehead Institute Member Rudolf Jaenisch, in collaboration with Lynda Chin from Dana Farber Cancer Institute.
› Verified 8 days ago
| Entity Name | Puerto Rico Pathology Associates P |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740246545 PECOS PAC ID: 4385655760 Enrollment ID: O20060523000117 |
News Archive
Hospitals still struggle to prevent avoidable healthcare-associated infections, according to a survey of infection preventionists released today by the Association for Professionals in Infection Control and Epidemiology. Half of those surveyed agree that catheter-related bloodstream infections continue to be a problem in their facilities and cite lack of time, resources, and the commitment of hospital leadership as hindering their ability to combat these infections more aggressively.
Research with a Finnish background facilitates the development of more effective cancer medication. Cancer cells have an exceptional ability to repair damage to their DNA caused during uncontrolled cell division.
An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma - pointing to a potential new target for treatment against the illness.
For a long time it has been known that the protein TOR - Target of Rapamycin - controls cell growth and is involved in the development of diseases such as cancer and diabetes. Researchers at the University of Basel's Biozentrum together with scientists from ETH Zurich have now examined the structure of mammalian TOR complex 1 (mTORC1) in more detail.
Nature can reset the clock in certain types of cancer and reverse many of the elements responsible for causing malignancy, reports a research team led by Whitehead Institute Member Rudolf Jaenisch, in collaboration with Lynda Chin from Dana Farber Cancer Institute.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manuel A Rivero Iturregui, MD 1760 Calle Loiza, Suite 203, San Juan, PR 00911-1801 Ph: (787) 726-5486 | Dr Manuel A Rivero Iturregui, MD 1760 Calle Loiza, Suite 203, San Juan, PR 00911-1801 Ph: (787) 726-5486 |
News Archive
Hospitals still struggle to prevent avoidable healthcare-associated infections, according to a survey of infection preventionists released today by the Association for Professionals in Infection Control and Epidemiology. Half of those surveyed agree that catheter-related bloodstream infections continue to be a problem in their facilities and cite lack of time, resources, and the commitment of hospital leadership as hindering their ability to combat these infections more aggressively.
Research with a Finnish background facilitates the development of more effective cancer medication. Cancer cells have an exceptional ability to repair damage to their DNA caused during uncontrolled cell division.
An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma - pointing to a potential new target for treatment against the illness.
For a long time it has been known that the protein TOR - Target of Rapamycin - controls cell growth and is involved in the development of diseases such as cancer and diabetes. Researchers at the University of Basel's Biozentrum together with scientists from ETH Zurich have now examined the structure of mammalian TOR complex 1 (mTORC1) in more detail.
Nature can reset the clock in certain types of cancer and reverse many of the elements responsible for causing malignancy, reports a research team led by Whitehead Institute Member Rudolf Jaenisch, in collaboration with Lynda Chin from Dana Farber Cancer Institute.
› Verified 8 days ago
Dr. Federico Salcedo-irizarry, MD Pathology Medicare: May Accept Medicare Assignments Practice Location: Asem (centro Medico De Pr), Pathology Department, Barrio Monacillos, San Juan, PR 00922 Phone: 787-777-3535 Fax: 787-777-3861 | |
Dr. William James Garner, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 Calle Del Muelle, 21007, San Juan, PR 00901 Phone: 917-653-0470 | |
Dr. Carlos A Castrodad-rodriguez, MD Pathology Medicare: Medicare Enrolled Practice Location: Hato Rey Pathology, 300 Calle Domenech, San Juan, PR 00918 Phone: 787-765-7320 | |
Mr. Jose Ramon Paz, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Arterial Hostos 1a Sotano, Capital Center Tone 1, San Juan, PR 00918 Phone: 787-751-1312 Fax: 787-751-5158 | |
Dr. Mohammad Nader Suleiman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1441 Calle J Ferrer Y Ferrer, San Juan, PR 00921 Phone: 787-528-7121 | |
Dr. Vicmari Arce Rodriguez, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 Ave Domenech, San Juan, PR 00918 Phone: 787-765-7320 Fax: 787-765-3230 | |
Dr. Gabriel Antonio Acosta Gonzalez, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1660 Loiza St, Madrid 206, San Juan, PR 00911 Phone: 787-726-5486 |